Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
6,870.00    115.00 (1.70%)
Bid:
6,855.00
Ask:
6,860.00
Spread: 5.00 (0.073%)
Market Cap: £30.42b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

Completion of Share Buyback Programme

22 Dec 2025 11:50

RNS Number : 4926M
Coca-Cola Europacific Partners plc
22 December 2025
 

Coca-Cola Europacific Partners plc (the "Company")Completion of Share Buyback Programme

 

The Company today announces that it has completed the share buyback programme (the "Programme") announced on 14 February 2025 to purchase up to a maximum aggregate amount of EUR 1 billion of the Company's ordinary shares.

The Company announces that 12,718,173 ordinary shares were repurchased under the Programme, for aggregate consideration of approximately EUR 999,998,769.23.[1]

As a result, the Company has returned EUR 999,998,769.23 to its shareholders through the completion of the Programme.

 

CONTACTS

Company Secretariat

Clare Wardle

clare.wardle@ccep.com

Investor Relations

Sarah Willett

sarah.willett@ccep.com

Media Relations

Shanna Wendt

mediaenquiries@ccep.com

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ (and a constituent of the NASDAQ 100), London Stock Exchange and on the Spanish Stock Exchanges, trading under the symbol CCEP (ISIN No. GB00BDCPN049).

For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

 

 

 

 

 


[1] The aggregate consideration of approximately EUR 999,998,769.23 is comprised of USD 832,273,272 spent on acquiring shares on the US Trading Venues (which comprise Nasdaq and other applicable US trading venues) and GBP 234,969,006 spent on acquiring depository interests on the London Trading Venues (which comprise the London Stock Exchange, CBOE Europe Limited (BXE), CBOE Europe Limited (CXE) and Aquis) over the course of the Programme.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFEWFFEEISEFE
Date   Source Headline
23rd Dec 20193:30 pmRNSDirector/PDMR Shareholding
17th Dec 20193:00 pmRNSDirector/PDMR Shareholding
4th Dec 20194:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20193:30 pmRNSTotal Voting Rights
20th Nov 20194:30 pmRNSDirector/PDMR Shareholding
15th Nov 201911:30 amRNSTransaction in Own Shares
8th Nov 201911:30 amRNSTransaction in Own Shares
1st Nov 20192:30 pmRNSTotal Voting Rights
1st Nov 20192:00 pmRNSTransaction in Own Shares
29th Oct 20194:30 pmRNSDirector/PDMR Shareholding
25th Oct 201912:30 pmRNSTransaction in Own Shares
24th Oct 20197:00 amRNSQ3 Trading Update & Interim Dividend Declaration
18th Oct 20192:00 pmRNSTransaction in Own Shares
11th Oct 20191:00 pmRNSTransaction in Own Shares
8th Oct 201910:30 amRNSDirector/PDMR Shareholding
4th Oct 201912:30 pmRNSTransaction in Own Shares
2nd Oct 20194:30 pmRNSHolding(s) in Company
2nd Oct 20193:30 pmRNSAdditional Listing
1st Oct 201912:30 pmRNSTotal Voting Rights
27th Sep 201912:30 pmRNSTransaction in Own Shares
20th Sep 201912:00 pmRNSTransaction in Own Shares
13th Sep 201911:30 amRNSTransaction in Own Shares
13th Sep 201911:00 amRNSDirector/PDMR Shareholding
13th Sep 201910:30 amRNSBlock Listing
10th Sep 20193:00 pmRNSDirector/PDMR Shareholding
6th Sep 201911:30 amRNSTransaction in Own Shares
4th Sep 201911:30 amRNSHolding(s) in Company
2nd Sep 20191:30 pmRNSTotal Voting Rights
30th Aug 201911:30 amRNSTransaction in Own Shares
28th Aug 20191:00 pmRNSChanges to senior management
23rd Aug 201911:30 amRNSTransaction in Own Shares
16th Aug 201911:30 amRNSTransaction in Own Shares
13th Aug 20193:00 pmRNSDirector/PDMR Shareholding
12th Aug 20193:30 pmRNSDirector/PDMR Shareholding
8th Aug 20197:00 amRNSCCEP Half-year Report 28 June 2019
7th Aug 20192:01 pmRNSNotice of Redemption
2nd Aug 201912:30 pmRNSTransaction in Own Shares
1st Aug 20192:30 pmRNSTotal Voting Rights
26th Jul 20191:00 pmRNSTransaction in Own Shares
19th Jul 20192:00 pmRNSChanges to senior management
19th Jul 201911:30 amRNSTransaction in Own Shares
12th Jul 20195:00 pmRNSDirector/PDMR Shareholding
12th Jul 20191:00 pmRNSTransaction in Own Shares
10th Jul 20191:00 pmRNSDirector/PDMR Shareholding
5th Jul 201911:30 amRNSTransaction in Own Shares
1st Jul 20191:30 pmRNSTotal Voting Rights
28th Jun 20193:30 pmRNSTransaction in Own Shares
21st Jun 201912:00 pmRNSTransaction in Own Shares
14th Jun 201912:00 pmRNSTransaction in Own Shares
12th Jun 20192:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.